Who Owns Agios Pharmaceuticals Stock?
NASDAQ: AGIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 112.29%
- Institutions (% of float)
- 113.50%
- Held by insiders
- 1.07%
- Institutional holders
- 318
- Institutions 98.9%
- Insiders 1.1%
- Public and other 0.0%
Who owns Agios Pharmaceuticals stock?
Institutional investors own about 112.3% of Agios Pharmaceuticals's shares, spread across 318 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.07% of AGIO.
The largest institutional holders are Blackrock Inc. (10.81%), Farallon Capital Management LLC (9.91%) and State Street Corporation (5.92%). Together, the top 10 institutions control 58.1% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their AGIO positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of AGIO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 6.46M | 10.81% | +12.2% |
| Farallon Capital Management LLC | 5.92M | 9.91% | +4.1% |
| State Street Corporation | 3.53M | 5.92% | +5.0% |
| Lynx1 Capital Management Lp | 3.41M | 5.71% | +30.5% |
| Shaw D.E. & Co., Inc. | 3.11M | 5.20% | +15.9% |
| Vanguard Portfolio Management LLC | 2.90M | 4.85% | +11.0% |
| Vanguard Capital Management LLC | 2.68M | 4.49% | +1.9% |
| Armistice Capital, LLC | 2.40M | 4.02% | -11.6% |
| Erste Asset Management GmbH | 2.15M | 3.61% | -20.3% |
| Nomura Asset Management International Inc | 2.11M | 3.54% | +41.2% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of AGIO
| Fund | Shares | % Held |
|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.11M | 3.54% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.89M | 3.16% |
| iShares Trust-iShares Russell 2000 ETF | 1.52M | 2.54% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.36M | 2.28% |
| Delaware Group Equity Funds V-Nomura Small Cap Core Fund | 1.14M | 1.92% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 788.65K | 1.32% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 683.99K | 1.15% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 646.32K | 1.08% |
| Fidelity Rutland Square TRT II-Strategic Advisers U.S. Total Stock Fd. | 539.56K | 0.90% |
| iShares Trust-iShares Russell 2000 Value ETF | 519.15K | 0.87% |
Frequently asked questions
Who is the largest shareholder of Agios Pharmaceuticals?
Blackrock Inc. is the largest institutional shareholder of AGIO, owning 10.81% of shares outstanding (6.46M shares) as of its latest 13F filing.
What percentage of Agios Pharmaceuticals is owned by institutions?
Institutions own about 112.3% of AGIO shares and 113.5% of the public float.
How much of Agios Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 1.07% of AGIO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.